Market revenue in 2020 | USD 89.1 million |
Market revenue in 2028 | USD 204.0 million |
Growth rate | 10.9% (CAGR from 2020 to 2028) |
Largest segment | Oncology |
Fastest growing segment | Personalized Medicine |
Historical data covered | 2018 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other Applications |
Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 38.95% in 2020. Horizon Databook has segmented the Latin America molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
Latin America’s cytogenetic development landscape is in a phase of significant development owing to increasing cases of genetic & congenital disorders along with remarkable growth in early detection of diseases, which are prime factors expected to fuel market growth over the forecast period.
Moreover, advent of innovative whole genome screening and sequencing techniques, such as chromosome microarray analysis and multiplex FISH, and technological advancements in molecular cytogenetic techniques like the comparative genomic hybridization and the fluorescence in situ hybridization are also expected to drive the market.
Government funding in countries such as Brazil, Colombia, and Argentina for introduction of newer sequencing technologies has helped researchers & manufacturers significantly and led to introduction of high-throughput diagnostic tools that would improve the cytogenetic landscape in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America molecular cytogenetics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account